Technical Analysis for RGLS - Regulus Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 1.11 2.78% 0.03
RGLS closed up 2.78 percent on Friday, January 18, 2019, on 1.44 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical RGLS trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 20 DMA Bullish 0.00%
Jan 18 Hammer Candlestick Bullish 0.00%
Jan 18 Doji - Bullish? Reversal 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Fell Below 20 DMA Bearish 2.78%
Jan 17 Wide Bands Range Expansion 2.78%
Jan 16 Wide Bands Range Expansion -2.63%
Jan 15 Pocket Pivot Bullish Swing Setup -3.48%
Jan 15 Volume Surge Other -3.48%
Jan 15 Wide Bands Range Expansion -3.48%

Older signals for RGLS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs to treat various diseases in the United States. The company utilizes its microRNA product platform to develop anti-miRs, a chemically modified single-stranded oligonucleotides. Its microRNA development candidates target miR-122 in hepatitis C virus infection; miR-21 and miR-221 in hepatocellular carcinoma; miR-21 in kidney fibrosis; miR-33 in atherosclerosis; and miR-10b in glioblastoma. The company has strategic alliances with AstraZeneca AB, GlaxoSmithKline plc, Sanofi, and Alnylam and Isis, as well as a strategic collaboration with Biogen Idec MA Inc. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California.
Is RGLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.8
52 Week Low 0.8
Average Volume 303,651
200-Day Moving Average 4.1609
50-Day Moving Average 1.3345
20-Day Moving Average 1.0973
10-Day Moving Average 1.159
Average True Range 0.1553
ADX 11.02
+DI 19.4669
-DI 23.7531
Chandelier Exit (Long, 3 ATRs ) 0.9041
Chandelier Exit (Short, 3 ATRs ) 1.2659
Upper Bollinger Band 1.3447
Lower Bollinger Band 0.8499
Percent B (%b) 0.53
BandWidth 45.0925
MACD Line -0.0609
MACD Signal Line -0.0761
MACD Histogram 0.0152
Fundamentals Value
Market Cap 115.2 Million
Num Shares 104 Million
EPS -1.53
Price-to-Earnings (P/E) Ratio -0.73
Price-to-Sales 450.54
Price-to-Book 2.98
PEG Ratio -0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.26
Resistance 3 (R3) 1.25 1.18 1.24
Resistance 2 (R2) 1.18 1.15 1.19 1.23
Resistance 1 (R1) 1.15 1.12 1.17 1.16 1.22
Pivot Point 1.08 1.08 1.09 1.09 1.08
Support 1 (S1) 1.05 1.05 1.07 1.06 1.00
Support 2 (S2) 0.98 1.02 0.99 0.99
Support 3 (S3) 0.95 0.98 0.99
Support 4 (S4) 0.96